Notes / Company

Brooks Laboratories Ltd.

BROOKS BSE 533543 ISIN INE650L01011 Pharmaceuticals

Fundamentals

Market cap: ₹217 cr
P/E: 8.81×
ROE: 0.00%
Debt / equity: 0.06
52-week range: 36.30 — 164.02

Research on Tijori Finance

Company snapshot

Brooks Laboratories Ltd.

Pharmaceuticals

₹204 cr

P/E 8.31×

Latest quarter · Mar 2026

Sales₹20 cr

Net profit₹1 cr

Op. margin+3.4%

EPS₹0.52

Strength & growth

Debt / equity0.06×

Current ratio1.48×

Sales CAGR+0.7%

EPS CAGR+2.6%

The timeline — 2 notes on Brooks Laboratories Ltd.

July 2026

16 Jul 26 · 6:29 PM IST Lead

Lead · Micro cap

Brooks Labs locks in ₹191 cr floor for retained stake in Steriscience

Binding MoU secures valuation floor, anti-dilution rights, and guarantee relief for the 32.67% holding, nearly matching the company's entire ₹206 cr market cap.

June 2026

19 Jun 26 · 9:34 PM IST Alert

Alert · Micro cap

Brooks Labs nets ₹106 cr from stake sale, 53% of its market cap

Partial monetisation of Brooks Steriscience stake fetches ₹106 crore in cash, a huge inflow for the nano-cap drug maker that nearly doubles its cash position.

Verify on exchange BSE filings for BROOKS NSE filings for BROOKS Tijori Finance company page